Controlled exogenous nitric oxide delivery

The patented technology delivers biologically relevant amounts of NO topically and orally for the treatment and prevention of infection, speeding the healing and resolution of acute and chronic wounds including burns and those with resistant strain infection, is autolytically debriding and stimulated healing ( regenerative medicine) to reduce healing time by approximately half without the need for biologics, all while improving cosmetic outcomes in all species. The technology is currently being expanded in the professional Animal Health market .

Pilot testing in the cosmetic space has also shown a significant benefit cascade for acute and chronic conditions such as psoriatic lesions. It is being readied for 510k approval with a strong predicate device in wound care.